Cellgebra

Cellgebra is at the forefront of biotechnology research, pioneering new strategies for target and biomarker discovery. With a focus on improving the success rate of cancer clinical trials, Cellgebra utilizes advanced mathematical models of cell type-specific signaling networks in cancer to predict patient response with high accuracy. By integrating information about thousands of DNA and RNA markers, Cellgebra aims to revolutionize patient stratification and significantly enhance clinical trial outcomes.

Located in the Synergy Center, TU Dublin, Tallaght, Dublin 24, Dublin, IE, Cellgebra is dedicated to developing innovative solutions for predicting drug resistance mechanisms and identifying novel therapeutic targets. The company’s approach allows for the integration of large-scale data, leading to more accurate and reliable predictions that can transform cancer treatment strategies.

Cellgebra's work extends to various model applications, ensuring comprehensive insights into cancer biology and treatment. We invite the management of Cellgebra to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking research and capabilities.